MINSK, 30 June (BelTA) – The National Academy of Sciences of Belarus (NASB) will set up a special research team to develop COVID-19 vaccine, Chairman of the NASB Presidium Vladimir Gusakov said on 30 June, BelTA has learned.
Belarusian scientists are studying the coronavirus and ways to diagnose and treat it. Belarus has established the national interagency working group for COVID-19 response. “We are currently looking into forming a special team of scientists to develop a vaccine,” Vladimir Gusakov noted. He said it will be a difficult task, because the coronavirus requires a special approach, so he cannot speak about the timeline of the project yet.
Belarusian scientists held videoconferences with their Russian and Chinese colleagues to work out a joint action plan. Russia is currently testing several vaccines. Several NASB institutes are also working in this field, Vladimir Gusakov said.
“We have adopted a comprehensive approach to the COVID-19 problem,” he remarked. Vladimir Gusakov spoke about various types of medicines, for example, some antivirus and immunomodulatory medicines, that have proven effective in treating coronavirus patients in Belarus.
The national interagency working group for COVID-19 response was set up by Resolution No.223 of the NASB Presidium of 18 May 2020. The group includes more than 30 specialists representing academic and university science. The aim of the group is to organize and coordinate the activities of scientists and medical professionals throughout the country to implement the measures to tackle the coronavirus.